You are asking the right question, how much do they need?
I did some math a few weeks back (can't remember what thread it was on), but essentially it gave a range of cash that was needed. To be honest, I do not know, we can only try and work backwards from what they have reported.
I suggest we should be thinking they need to jab / test between 300 to 650 people at a cost of circa US$50k each. I would err on the high side, given I think the FDA will ask for all the same monitoring from phase 1
I will dig out those previous thoughts.
Where we at?, page-405
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $103.2K | 409.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16577 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 10906 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.5¢ |
Change
0.000 ( 1.39 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 25.5¢ | 25.0¢ | 204618 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| PAR (ASX) Chart |